Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
EDITOR,--While I welcome new initiatives in the management of breast cancer, I believe that the study by Eva Grunfeld and colleagues must be interpreted with caution.1 The authors report no delay in the diagnosis of recurrent breast cancer or reduction in the quality of life of patients randomised to follow up by their general practitioner, but their conclusions must be questioned. The data on recurrence are based on a short follow up (18 months) and small numbers (10 women followed up by their general practitioner, 16 followed up in hospital), and the comparisons of quality of life are flawed. Women randomised to follow up by their general practitioner knew that they were under special surveillance, which is different from being "discharged" from hospital. A third of women declined to enter the trial even under these circumstances.
Guidelines drawn up by the breast
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?